Sarepta Therapeutics
SRPT
SRPT
341 hedge funds and large institutions have $2.01B invested in Sarepta Therapeutics in 2025 Q4 according to their latest regulatory filings, with 70 funds opening new positions, 135 increasing their positions, 90 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.23% more ownership
Funds ownership: 88.85% → 89.08% (+0.23%)
16% less call options, than puts
Call options by funds: $114M | Put options by funds: $136M
Holders
341
Holding in Top 10
–
Calls
$114M
Puts
$136M
Top Buyers
| 1 | +$135M | |
| 2 | +$27.3M | |
| 3 | +$22.8M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$20.9M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$18.8M |
Top Sellers
| 1 | -$31.4M | |
| 2 | -$22.2M | |
| 3 | -$20.2M | |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
-$16M |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$14M |
